This year, Alkaloid is participating in CPHI (Convention on Pharmaceutical Ingredients) for the 23rd time, a leading global event that brings together stakeholders from across the pharmaceutical value chain. Held from 6 to 8 October in Milan, Italy, the 37th edition of CPHI convenes the global pharmaceutical community for networking, knowledge exchange, showcasing innovations, and forging new business opportunities.

Set against the backdrop of Alkaloid's 90th anniversary, this year's presentation at CPHI Milan 2026 focuses on the company's state-of-the-art manufacturing facilities, comprehensive product portfolio, and key development milestones.

Throughout the three-day event, Alkaloid’s team of 35 representatives from across the company is holding a series of meetings with existing partners, suppliers, and prospective collaborators. The main focus is strengthening long-standing relationships, exploring new business opportunities, and expanding international cooperation with leading stakeholders across the pharmaceutical industry.

With more than 62,000 pharmaceutical professionals and over 2,900 exhibitors from around the world, CPHI is one of the most renowned global gatherings in the pharmaceutical industry. It brings together companies, experts, and innovators, providing a dynamic platform for showcasing the latest technologies and establishing strategic partnerships that unlock new opportunities for the development of next-generation innovative pharmaceutical solutions.

Alkaloid’s continued presence at CPHI reflects the company’s long-term commitment to remaining at the forefront of global developments in the pharmaceutical industry, strengthening its international competitiveness and building a foundation for sustainable future growth through new knowledge, technologies, and partnerships.